|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||
| Interest-bearing deposits with banks | ||||||||||||||||||
| Federal funds sold | ||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||
| Investment securities available-for-sale, amortized cost of $4,245,206 and allowance for credit losses of zero at June 30, 2021 and amortized cost of $3,249,067 and allowance for credit losses of zero at December 31, 2020 | ||||||||||||||||||
| Investment securities held-to-maturity (estimated fair value of $311 at December 31, 2017) | ||||||||||||||||||
| Equity securities with readily determinable fair values not held for trading | ||||||||||||||||||
| FRB and FHLB stock | ||||||||||||||||||
| Loans held for sale | ||||||||||||||||||
| Loans, net of unearned income | ||||||||||||||||||
| Less: allowance for credit losses | ||||||||||||||||||
| Net loans | ||||||||||||||||||
| Interest receivable | ||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||
| Other real estate owned | ||||||||||||||||||
| Cash surrender value of life insurance | ||||||||||||||||||
| Net deferred tax asset | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||
| Liabilities: | ||||||||||||||||||
| Noninterest-bearing deposits | ||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||
| Total deposits | ||||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||
| Senior debt | ||||||||||||||||||
| Subordinated debt | ||||||||||||||||||
| Junior subordinated debentures | ||||||||||||||||||
| Notes payable | ||||||||||||||||||
| Net deferred tax liability | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||
| Common stock, $0.01 par value, authorized 300,000,000 shares; 133,562,513 shares issued and 124,752,738 shares outstanding at June 30, 2021 and 133,214,844 shares issued and 125,978,561 shares outstanding at December 31, 2020 | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Treasury stock, at cost; 8,809,775 shares and 7,236,283 shares, respectively | ||||||||||||||||||
| Retained earnings | ||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||
| Total liabilities and shareholders' equity |
Loading...
